Our work delves into the mechanisms of retinal diseases and aging, while exploring the potential therapeutic benefits of dietary restrictions (DR). We aim to uncover cell-specific responses to DR that could lead to developing treatments for a variety of genetically heterogeneous inherited retinal diseases that have proven very difficult to target.
Dietary restriction is a potent intervention for extending organismal lifespan and healthspan of a wide variety of tissues, including the eye! Gaining a better understanding of how cells respond to DR to obtain this benefit could unlock new ways to treat eye diseases and slow retinal aging.Â
Mutations in over 150 different genes can cause retinitis pigmentosa. Patient populations for individual genes are quite small, posing a significant hurdle to developing targeted gene replacement therapies. Recently, several approaches have been developed which have the potential to treat RP regardless of the underlying mutations. I hope to add to this progress by taking advantage of the photoreceptor and RPE cellular responses to dietary restriction.
I employ diverse tools to advance these goals, bridging the discovery capabilities of Drosophila with the translational relevance of zebrafish and cultured human cells.